DVA

DaVita Inc

176.69

Oct 21 • 3:59 PM ET +1.34 (0.76%)

176.81

Aftermarket • 4:06 PM ET +0.12 (0.07%)

Healthcare Medical Care Facilities USA Large NYSE

Oct 20, 2:02 PMHHS kidney-market competition plan sends DaVita down 6% in Tuesday regular trading

Peers: FMS THC EHC OPCH HCA UHS SGRY ASTH OM RMTI

| Held by: VTI RSP VOO VB VBR IVV SPY DFAS DFAC OMAH

Scroll to Statements

Index	S&P 500
Market Cap	11.27B
Enterprise Value	25.75B
Income	822.48M
Sales	14.01B
Book/sh	-13.03
Cash/sh	12.10
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	78000
IPO	Oct 31, 1995

P/E	14.90
Forward P/E	10.42
PEG	0.48
P/S	0.80
P/B	-
P/C	14.61
P/FCF	7.00
EV/EBITDA	9.19
EV/Sales	1.84
Quick Ratio	1.41
Current Ratio	1.47
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	11.86
EPS next Y	16.96
EPS next Q	3.57
EPS this Y	37.52%
EPS next Y	14.42%
EPS next 5Y	21.92%
EPS past 3/5Y	18.56% 8.29%
Sales past 3/5Y	5.53% 3.39%
EPS Y/Y TTM	16.30%
Sales Y/Y TTM	6.45%
EPS Q/Q	55.84%
Sales Q/Q	5.17%
Earnings	Oct 29 AMC
EPS/Sales Surpr.	3.55% 1.65%

Insider Own	2.08%
Insider Trans	-54.31%
Inst Own	93.39%
Inst Trans	-3.46%
ROA	4.67%
ROE	-
ROIC	6.81%
Gross Margin	27.29%
Oper. Margin	14.93%
Profit Margin	5.87%
SMA20	-1.53%
SMA50	-2.03%
SMA200	1.34%
Trades

Shs Outstand	63.80M
Shs Float	62.48M
Short Float	8.24%
Short Ratio	6.66
Short Interest	5.15M
52W High	247.49 -28.61%
52W Low	101.00 74.94%
Volatility	4.29% 2.78%
ATR (14)	5.65
RSI (14)	43.58
Beta	0.88
Rel Volume	1.48
Avg Volume	772.67K
Volume	1,140,507

Perf Week	-2.22%
Perf Month	-3.83%
Perf Quarter	-24.58%
Perf Half Y	15.92%
Perf YTD	55.52%
Perf Year	37.60%
Perf 3Y	127.93%
Perf 5Y	53.10%
Perf 10Y	189.85%
Recom	2.27
Target Price	229.00
Prev Close	175.35
Price	176.69
Change %	0.76%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-26	Upgrade	TD Cowen	Hold → Buy	$220
May-06-26	Upgrade	Deutsche Bank	Hold → Buy	$220
Mar-06-24	Initiated	Barclays	Equal Weight	$133
Aug-07-23	Upgrade	UBS	Neutral → Buy	$100 → $142
Nov-01-22	Downgrade	Deutsche Bank	Buy → Hold	$97 → $72
Oct-31-22	Downgrade	UBS	Buy → Neutral	$117 → $74
Aug-19-22	Resumed	UBS	Buy	$106 → $117
Jun-21-22	Reiterated	BofA Securities	Underperform	$110 → $90
Sep-10-21	Initiated	Cowen	Market Perform	$145
Aug-12-21	Downgrade	Barclays	Overweight → Equal Weight	$135 → $146
Mar-26-21	Downgrade	BofA Securities	Neutral → Underperform	$127 → $118
Jan-05-21	Downgrade	BofA Securities	Buy → Neutral	$127
Jan-24-20	Upgrade	Goldman	Neutral → Buy	$72 → $97
Nov-07-19	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-25-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-11-19	Downgrade	William Blair	Outperform → Mkt Perform
Jul-26-19	Downgrade	Robert W. Baird	Outperform → Neutral	$70 → $65
Jan-08-19	Upgrade	UBS	Sell → Neutral
Jan-03-19	Initiated	Deutsche Bank	Buy	$60
Dec-14-18	Initiated	Barclays	Overweight

Show Previous Ratings

Oct-20-26 07:23PM	DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice (PR Newswire) -6.23%
04:30PM	DaVita Inc. stock underperforms Tuesday when compared to competitors (MarketWatch)
Oct-19-26 05:37PM	DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call (PR Newswire)
Oct-15-26 09:00AM	DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care (PR Newswire)
Oct-08-26 04:00PM	DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early (PR Newswire)
04:30PM	Loading…
Sep-24-26 04:30PM	DaVita Inc. stock underperforms Thursday when compared to competitors (MarketWatch)
Sep-17-26 04:30PM	DaVita Inc. stock underperforms Thursday when compared to competitors (MarketWatch) -5.56%
Sep-14-26 09:40AM	DaVita Community Care Report 2025: Empowering Teammates Through Career Development and Education (ACCESSWIRE)
Sep-08-26 09:35AM	Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 (ACCESSWIRE)
Sep-02-26 07:23AM	DaVita agrees to pay $15M to settle claims from data breach (Healthcare Dive)
Aug-26-26 06:47AM	Alebund Pharmaceuticals Announces 2026 Interim Results (PR Newswire)
Aug-25-26 07:07AM	DaVita and Humana Expand Kidney Care Partnership to More Than 10,000 Patients (InvestorsHub)
06:00AM	DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease (PR Newswire)
Aug-14-26 05:29PM	Berkshire ups Alphabet stake under Greg Abel, making it a top-3 holding (Yahoo Finance Video)
Aug-12-26 10:45AM	S&P 500 Earnings Are So Good Investors Are Starting to Worry (Bloomberg)
06:34AM	Loading…
Aug-07-26 06:34AM	DaVita Shares Rise After TD Cowen Upgrades Stock to Buy (InvestorsHub)
Aug-05-26 04:30PM	DaVita Inc. stock underperforms Wednesday when compared to competitors (MarketWatch) -17.24%
08:30AM	DaVita Inc. Q2 2026 Earnings Call Summary (Moby)
01:03AM	DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volume Growth and Strategic ... (GuruFocus.com)
Aug-04-26 04:05PM	DaVita Inc. 2nd Quarter 2026 Results (PR Newswire)
Jul-21-26 05:00PM	DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call (PR Newswire)
May-18-26 03:00PM	DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals (PR Newswire)
May-12-26 10:41AM	Rosarium Health Raises $6M In Seed Funding Round To Provide Reliable And Faster In-Home Care For Aging Populations (AfroTech)
May-06-26 06:01PM	DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference (PR Newswire) +23.46%
May-05-26 04:05PM	DaVita Inc. 1st Quarter 2026 Results (PR Newswire)
Apr-20-26 02:06PM	DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call (PR Newswire)
Mar-31-26 08:06PM	Should Value Investors Buy DaVita (DVA) Stock? (Quartz)
Mar-18-26 03:00PM	DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement (PR Newswire)
Mar-06-26 11:49AM	Here's Why You Should Add DaVita Stock to Your Portfolio for Now (Zacks)
Mar-05-26 12:40PM	Is DaVita Inc. (DVA) A Good Stock To Buy? (Insider Monkey)
11:30AM	Loading…
Mar-04-26 11:30AM	DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue? (Zacks)
10:08AM	Jim Cramer on DaVita: "Haven't Seen That Stock Do That Well In This Long" (Insider Monkey)
Mar-03-26 06:56PM	How Berkshire Hathaway Performed During Buffett's Final Quarter (MarketBeat)
Feb-27-26 04:48AM	New Strong Buy Stocks for February 27th (Zacks)
04:03AM	Best Value Stocks to Buy for February 27th (Zacks)
03:50AM	Best Growth Stocks to Buy for February 27th (Zacks)
Feb-24-26 02:00PM	DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference (PR Newswire)
09:40AM	Here's Why DaVita HealthCare (DVA) is a Strong Value Stock (Zacks)
02:53AM	Best Value Stocks to Buy for February 24th (Zacks)
Feb-23-26 09:40AM	Is DaVita (DVA) Stock Undervalued Right Now? (Zacks)
Feb-20-26 09:50AM	Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term (Zacks)
04:09AM	Zacks.com featured highlights include DaVita, Ford, Centerra, Southwest Airlines and Patria Investments (Zacks)
Feb-19-26 09:20AM	5 Value Stocks to Buy Now as Fed Debates Next Rate Move (Zacks)
05:30AM	New Strong Buy Stocks for February 19th (Zacks)
04:34AM	Best Value Stocks to Buy for February 19th (Zacks)
Feb-17-26 04:53PM	Buffett's Final Filing: Berkshire Initiates New York Times Stake, Slashes Amazon Position Before CEO Transition (Benzinga)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks)
Feb-12-26 11:03AM	BAX Stock Falls Following Q4 Earnings Miss, Margins Contract (Zacks)
10:54AM	INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands (Zacks)
10:41AM	AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline (Zacks)
09:25AM	QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down (Zacks)
Feb-11-26 09:15AM	Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? (Zacks)
Feb-10-26 12:30PM	ECL Stock Falls in Pre-Market Despite Q4 Earnings Beat, Margins Expand (Zacks)
09:32AM	4 Discounted PEG Value Stocks to Boost Your Portfolio's Health (Zacks)
Feb-09-26 10:38AM	BD Stock Dips in Pre-Market Despite Q1 Earnings Beat, Margins Up (Zacks)
08:50AM	DaVita Stock: Is Wall Street Bullish or Bearish? (Barchart)
12:31AM	The 5 Most Interesting Analyst Questions From DaVita's Q4 Earnings Call (StockStory)
Feb-05-26 09:40AM	Should Value Investors Buy DaVita (DVA) Stock? (Zacks) +5.04%
09:40AM	Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term (Zacks)
Feb-04-26 07:55PM	Analyst Report: DaVita Inc. (Morningstar Research) +5.44%
02:54PM	3 Warren Buffett-Style Stocks for a Golden Retirement (24/7 Wall St.)
10:59AM	DaVita (DVA) Q1 2025 Earnings Call Transcript (Motley Fool)
Feb-03-26 06:03PM	Stocks to Watch Tuesday Recap: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal) +21.17%
04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
01:18PM	Stocks Fall, Gold Rallies On Best Day Since 2008: What's Moving Markets Tuesday? (Benzinga)
12:38PM	What Sent DaVita Stock Soaring On Tuesday? (Motley Fool)
12:25PM	DaVita Stock Rallies On Profit Beat, Confident 2026 View (Benzinga)
11:45AM	Why Is DaVita (DVA) Stock Rocketing Higher Today (StockStory)
11:16AM	This Berkshire Hathaway Holding Is Up 25%. Earnings Breeze Past Estimates. (Barrons.com)
11:14AM	Software Stocks Retreat and Drag the Broader Market Lower (Barchart)
10:23AM	DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand (Zacks)
09:59AM	Nasdaq Slips, Gold and Silver Stage Substantial Recovery (Barchart)
09:40AM	Stocks to Watch Tuesday: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
08:10AM	DVA Q4 Deep Dive: Clinical Initiatives and Integrated Care Drive Outlook Amid Margin Compression (StockStory)
05:54AM	Teradyne's 'blowout' guidance sees stock surge, and other early movers (MarketWatch)
12:01AM	DaVita Inc (DVA) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges (GuruFocus.com)
Feb-02-26 09:55PM	Analyst Report: DaVita Inc. (Morningstar Research)
08:40PM	DaVita Inc. (DVA): A Bull Case Theory (Insider Monkey)
06:38PM	DaVita Q4 Earnings Call Highlights (MarketBeat)
05:20PM	DaVita HealthCare (DVA) Q4 Earnings and Revenues Surpass Estimates (Zacks)
04:20PM	DaVita (NYSE:DVA) Beats Expectations in Strong Q4 CY2025, Stock Soars (StockStory)
04:05PM	DaVita Inc. 4th Quarter 2025 Results (PR Newswire)
03:00PM	Elara Caring Secures New Strategic Investment from Ares and DaVita (Business Wire)
Jan-31-26 10:01PM	DaVita (DVA) Q4 Earnings: What To Expect (StockStory)
Jan-30-26 11:56AM	Can Operational Execution Support DaVita's Q4 Performance? (Zacks)
Jan-29-26 11:34PM	3 Healthcare Stocks We Steer Clear Of (StockStory)
Jan-27-26 06:00PM	DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-21-26 06:15PM	DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know (Zacks)
10:00AM	DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call (PR Newswire)
Jan-19-26 12:31PM	Here's Why You Should Hold DaVita Stock in Your Portfolio for Now (Zacks)
Jan-16-26 01:56PM	Hedge Funds Are Shorting This Classic Warren Buffett Stock. Should You Sell Shares Now? (Barchart)
04:25AM	DaVita - In the sweet spot of Growth and Value (GuruFocus.com)
Jan-15-26 10:34AM	Here's What to Expect From DaVita's Next Earnings Report (Barchart)
Jan-14-26 11:50AM	Behind Berkshires Curtain: Is Greg Abel Preparing to Cut Davita Loose? (Barchart)
Jan-13-26 06:00PM	DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -5.11%
Jan-07-26 06:00PM	Why DaVita HealthCare (DVA) Dipped More Than Broader Market Today (Zacks)
06:00AM	What Is the Plan for Berkshire Hathaway's $300 Billion Equity Portfolio Following Warren Buffett's Retirement? (Motley Fool)
Jan-02-26 09:32AM	Warren Buffetts Likely Replacement as Berkshires Top Stock Picker Has a Lot to Prove (Barrons.com)
Dec-29-25 08:53AM	Meet the New Berkshire, Same as the Old Berkshire (Barrons.com)
01:30AM	Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. (Barrons.com)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BERKSHIRE HATHAWAY INC	10% Owner	Jul 31 '26	Sale	199.55	182,980	36,513,293	28,697,229	Aug 04 05:27 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Jun 15 '26	Sale	208.40	15,405	3,210,377	109,194	Jun 17 06:10 PM
Rodriguez Javier	Chief Executive Officer	Jun 16 '26	Sale	209.28	39,407	8,247,018	840,408	Jun 17 06:09 PM
Rodriguez Javier	Chief Executive Officer	Jun 15 '26	Sale	209.50	30,000	6,285,090	879,815	Jun 17 06:09 PM
Javier Rodgriguez	Officer	Jun 16 '26	Proposed Sale	209.28	39,407	8,247,016		Jun 16 04:44 PM
Kathleen Waters	Officer	Jun 15 '26	Proposed Sale	207.84	8,950	1,860,202		Jun 15 04:53 PM
Javier Rodriguez	Officer	Jun 15 '26	Proposed Sale	209.50	30,000	6,285,102		Jun 15 04:48 PM
Waters Kathleen Alyce	Officer	Jun 15 '26	Proposed Sale	207.93	6,455	1,342,188		Jun 15 04:10 PM
HEARTY JAMES O	Chief Compliance Officer	May 14 '26	Option Exercise	110.63	5,784	639,884	41,737	May 18 04:08 PM
HEARTY JAMES O	Chief Compliance Officer	May 15 '26	Sale	193.98	15,000	2,909,745	22,389	May 18 04:08 PM
James Hearty	Officer	May 15 '26	Proposed Sale	193.93	15,000	2,908,950		May 15 03:12 PM
Maughan David Paul	Chief Operating Officer, DKC	May 12 '26	Sale	199.25	13,456	2,681,162	94,105	May 13 04:10 PM
Maughan David Paul	Chief Operating Officer, DKC	May 11 '26	Sale	199.15	7,073	1,408,581	107,561	May 13 04:10 PM
David Maughan	Officer	May 11 '26	Proposed Sale	198.03	20,529	4,065,340		May 11 05:40 PM
ACKERMAN JOEL	CFO and Treasurer	May 07 '26	Sale	192.10	51,471	9,887,528	132,434	May 11 04:05 PM
HEARTY JAMES O	Chief Compliance Officer	May 06 '26	Sale	174.87	2,184	381,916	35,953	May 08 04:04 PM
Joel Ackerman	Officer	May 07 '26	Proposed Sale	191.50	51,471	9,856,696		May 07 04:43 PM
HEARTY JAMES O	Officer	May 06 '26	Proposed Sale	169.28	2,184	369,708		May 06 04:03 PM
BERKSHIRE HATHAWAY INC	10% Owner	May 01 '26	Sale	149.84	1,220,376	182,864,679	28,880,209	May 05 06:52 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Feb 06 '26	Option Exercise	108.93	8,079	880,045	105,833	Feb 09 06:57 PM
ACKERMAN JOEL	CFO and Treasuer	Feb 06 '26	Option Exercise	108.93	44,065	4,800,000	185,705	Feb 09 06:56 PM
BERKSHIRE HATHAWAY INC	10% Owner	Jan 29 '26	Sale	120.56	1,658,480	199,939,881	30,100,585	Feb 02 05:30 PM
HEARTY JAMES O	Chief Compliance Officer	Dec 04 '25	Option Exercise	108.93	5,875	639,964	31,913	Dec 05 04:35 PM
BERKSHIRE HATHAWAY INC	10% Owner	Oct 27 '25	Sale	135.36	401,514	54,347,249	31,759,065	Oct 29 06:09 PM

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

CEO & Executive DirectorMr. Javier J. Rodriguez

CFO & TreasurerMr. Joel Ackerman

Chief Legal & Public Affairs OfficerMs. Kathleen Alyce Waters

Chief Compliance OfficerMr. James O. Hearty

Chief Operating Officer of DaVita Kidney CareMr. David P. Maughan

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DVA

DaVita Inc

Upgrade your Finviz experience